Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
adults and children 6 years and over 1 capsule daily; not more than 1 capsule in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
safety sealed: do not use if the individual blister unit imprinted with Claritin® Liqui-Gels® is open or torn store between 20° to 25°C (68° to 77°F) protect from freezing
Drug Facts
Loratadine 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 6 years and over | 1 capsule daily; not more than 1 capsule in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
caprylic/capric glycerides, FD&C blue no.1, gelatin, glycerin, pharmaceutical ink, polysorbate 80, povidone, purified water, sorbitol
1-800-CLARITIN (1-800-252-7484)
Pat.: patents.livewell.bayer.com
Bayer, the Bayer Cross, Claritin and the Claritin Vista are registered trademarks of Bayer.
© 2023 Bayer. Dist by: Bayer HealthCare LLC
Whippany, NJ 07981
LIQUI-GELS is a registered trademark of Catalent Pharma Colutions, Inc.
Non-Drowsy*
Claritin
®
Liqui-Gels®
24
Hour
Relief of:
loratadine 10 mg/antihistamine
Indoor & Outdoor Allergies
Allergies
*When taken as directed.
See Drug Facts Panel.
30 LIQUID-FILLED
CAPSULES
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 836338 | Claritin Liqui-Gels 10 MG 24HR Oral Capsule | PSN | 13 |
| 828269 | loratadine 10 MG 24HR Oral Capsule | PSN | 13 |
| 836338 | loratadine 10 MG Oral Capsule [Claritin] | SBD | 13 |
| 828269 | loratadine 10 MG Oral Capsule | SCD | 13 |
| 836338 | Claritin 10 MG Oral Capsule | SY | 13 |
| 828269 | loratadine 10 MG 24HR Oral Capsule | SY | 13 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0041100807984 | GTIN-13: 0041100807984 EAN-13: 0041100807984 GTIN-12: 041100807984 UPC-A: 041100807984 GTIN storage (14 digits): 00041100807984 | Claritin 24hr LiquiGels 30 Count DFL.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-7200-1 | ClaritinLiqui-Gels | 1 in 1 CARTON | CAPSULE, LIQUID FILLED | 1 | 13 | |
| 11523-7200-1 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7200-2 | ClaritinLiqui-Gels | 8 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 8 | 13 | |
| 11523-7200-2 | ClaritinLiqui-Gels | 3 in 1 CARTON | CAPSULE, LIQUID FILLED | 3 | 13 | |
| 11523-7200-3 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7200-3 | ClaritinLiqui-Gels | 4 in 1 CARTON | CAPSULE, LIQUID FILLED | 4 | 13 | |
| 11523-7200-4 | ClaritinLiqui-Gels | 7 in 1 CARTON | CAPSULE, LIQUID FILLED | 7 | 13 | |
| 11523-7200-4 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7200-5 | ClaritinLiqui-Gels | 1 in 1 POUCH | CAPSULE, LIQUID FILLED | 1 | 13 | |
| 11523-7200-6 | ClaritinLiqui-Gels | 3 in 1 CARTON | CAPSULE, LIQUID FILLED | 3 | 13 | |
| 11523-7200-6 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7200-7 | ClaritinLiqui-Gels | 5 in 1 CARTON | CAPSULE, LIQUID FILLED | 5 | 13 | |
| 11523-7200-7 | ClaritinLiqui-Gels | 9 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 9 | 13 | |
| 11523-7200-8 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7200-8 | ClaritinLiqui-Gels | 4 in 1 CARTON | CAPSULE, LIQUID FILLED | 4 | 13 | |
| 11523-7200-9 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7200-9 | ClaritinLiqui-Gels | 6 in 1 CARTON | CAPSULE, LIQUID FILLED | 6 | 13 | |
| 11523-7333-1 | ClaritinLiqui-Gels | 5 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 5 | 13 | |
| 11523-7333-1 | ClaritinLiqui-Gels | 1 in 1 CARTON | CAPSULE, LIQUID FILLED | 1 | 13 | |
| 11523-7333-3 | ClaritinLiqui-Gels | 9 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 9 | 13 | |
| 11523-7333-3 | ClaritinLiqui-Gels | 4 in 1 CARTON | CAPSULE, LIQUID FILLED | 4 | 13 | |
| 11523-7333-4 | ClaritinLiqui-Gels | 7 in 1 CARTON | CAPSULE, LIQUID FILLED | 7 | 13 | |
| 11523-7333-4 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7333-5 | ClaritinLiqui-Gels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 13 | |
| 11523-7333-5 | ClaritinLiqui-Gels | 10 in 1 CARTON | CAPSULE, LIQUID FILLED | 10 | 13 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-7200-1 | EA - Each | 11523-7200 | aadf47aa-87c1-425b-a7f6-67866160edcb | 1 | 2013-02-13 |
| 11523-7200-2 | EA - Each | 11523-7200 | 7facd762-a51d-45fa-94f1-ce08487f429c | 1 | 2013-02-13 |
| 11523-7200-3 | EA - Each | 11523-7200 | 76a5d6cf-4345-48d9-8064-dfa7d481a898 | 1 | 2013-02-13 |
| 11523-7200-6 | EA - Each | 11523-7200 | bae274e3-4d2c-4f8a-b379-0ac97ba5a8cd | 1 | 2015-03-03 |
| 11523-7200-7 | EA - Each | 11523-7200 | c435ae2a-e01a-4fc3-89c0-5b1f9b83e231 | 1 | 2015-10-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Loratadine | ACTIVE INGREDIENT | 7AJO3BO7QN | 3 | |
| Loratadine | ACTIVE MOIETY | 7AJO3BO7QN | 3 | |
| FD&C blue no. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 3 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | 3 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 3 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | 3 | |
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | 3 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11523-7200 | 11523-7200-1, 11523-7200-2, 11523-7200-3, 11523-7200-5, 11523-7200-4, 11523-7200-6, 11523-7200-7, 11523-7200-8, 11523-7200-9 |
| 11523-7333 | 11523-7333-1, 11523-7333-3, 11523-7333-4, 11523-7333-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GELATIN | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| POVIDONE | FZ989GH94E | IACT |
| WATER | 059QF0KO0R | IACT |
| SORBITOL | 506T60A25R | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| POVIDONE | FZ989GH94E | IACT |
| WATER | 059QF0KO0R | IACT |
| SORBITOL | 506T60A25R | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| GELATIN | 2G86QN327L | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE / ORAL | 418.37 mg | ||
| povidones | POVIDONE | FZ989GH94E | CAPSULE, EXTENDED RELEASE / ORAL | 56 mg | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, CHEWABLE / ORAL | 24 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | FILM, SOLUBLE / ORAL | 0.04 mg | ||
| gelatin | GELATIN | 2G86QN327L | TABLET / PERIODONTAL | 3.44 mg | ||
| sorbitol | SORBITOL | 506T60A25R | TABLET, EXTENDED RELEASE / ORAL | 428 mg | ||
| gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 14 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, DELAYED RELEASE / ORAL | 4 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION, SOLUTION / INTRAVENOUS | 4050 mg | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 14 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, CHEWABLE / ORAL | 84 mg | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, SUGAR COATED / ORAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 0.01 mg | ||
| gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED / ORAL | 288 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, LIQUID FILLED / ORAL | 24 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRA-ARTICULAR | 4 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, ORALLY DISINTEGRATING / ORAL | 15.03 mg | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | MOUTHWASH / BUCCAL | NA | ||
| gelatin | GELATIN | 2G86QN327L | PASTILLE / ORAL | 143 mg | ||
| gelatin | GELATIN | 2G86QN327L | CAPSULE / ORAL | 10932 mg | ||
| sorbitol | SORBITOL | 506T60A25R | LOTION / TOPICAL | 10.7 %w/w | ||
| sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / BUCCAL | 5110 mg | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| gelatin | GELATIN | 2G86QN327L | POWDER / ORAL | 100 mg | ||
| gelatin | GELATIN | 2G86QN327L | INJECTION / INTRACAVITARY | 0.05 ml | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, COATED / ORAL | 18 mg | ||
| gelatin | GELATIN | 2G86QN327L | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.3 %w/v | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRASYNOVIAL | 0.2 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAVENOUS | 4680 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 4739 mg | ||
| gelatin | GELATIN | 2G86QN327L | INJECTION, SUSPENSION / INTRAMUSCULAR | 1.3 mg | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, SUGAR COATED / ORAL | NA | ||
| sorbitol | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1.04 %w/v | ||
| povidones | POVIDONE | FZ989GH94E | SOLUTION / OPHTHALMIC | 1.8 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRALESIONAL | 45 %w/v | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, FILM COATED / ORAL | 57 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRA-ARTICULAR | 45 %w/v | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / RESPIRATORY (INHALATION) | 1 mg | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SOLUTION / RECTAL | 0.01 %w/v | ||
| povidones | POVIDONE | FZ989GH94E | POWDER, FOR SUSPENSION / ORAL | 35 mg/5ml | ||
| gelatin | GELATIN | 2G86QN327L | TABLET / ORAL | 46 mg | ||
| sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 5 mg | ||
| povidones | POVIDONE | FZ989GH94E | SUSPENSION / OPHTHALMIC | 1.8 %w/v | ||
| povidones | POVIDONE | FZ989GH94E | SOLUTION / ORAL | 3000 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021952-001 | CLARITIN | LORATADINE | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021952-001 | CLARITIN | 10MG | CAPSULE / ORAL | RLD, RS | 2008-06-16 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4a2b0359-b6f2-ddf9-e063-6294a90aed99 | 8e14b61f-faf6-43a8-a080-75f64514217a | 2026-02-06 | Warnings | 4a2b0359-b6f2-ddf9-e063-6294a90aed99 8e14b61f-faf6-43a8-a080-75f64514217a |
Adverse event summaries are temporarily unavailable. Other product information remains available.